Viewing Study NCT02810951


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-02-28 @ 9:31 AM
Study NCT ID: NCT02810951
Status: TERMINATED
Last Update Posted: 2023-02-08
First Post: 2016-06-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Sponsor: Castle Creek Biosciences, LLC.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epidermolysis Bullosa Dystrophica, Recessive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RDEB View